Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 17, 2024

SELL
$233.45 - $247.73 $17,275 - $18,332
-74 Closed
0 $0
Q4 2023

Jan 17, 2024

SELL
$232.24 - $267.23 $4,877 - $5,611
-21 Reduced 22.11%
74 $18,000
Q2 2023

Jul 05, 2023

BUY
$238.39 - $265.32 $238 - $265
1 Added 1.06%
95 $25,000
Q3 2022

Oct 12, 2022

SELL
$51.03 - $264.23 $24,035 - $124,452
-471 Reduced 83.36%
94 $21,000
Q2 2022

Oct 12, 2022

BUY
$234.74 - $275.42 $469 - $550
2 Added 0.36%
565 $139,000
Q4 2021

Mar 11, 2022

BUY
$230.08 - $250.94 $460 - $501
2 Added 0.36%
563 $145,000
Q3 2021

Nov 16, 2021

BUY
$232.72 - $256.47 $130,555 - $143,879
561 New
561 $137,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Kozak & Associates, Inc. Portfolio

Follow Kozak & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kozak & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kozak & Associates, Inc. with notifications on news.